uestion You are a financial manager that wants to know projected cash flows next year for decision-making purposes. Below is some financial statement information that is loosely based on Pfizer (symbol: PFE) for the year ended December 31, 2016 Income Statement (in millions ) Year Ended December 31, 2016 Sales Cost of Sales Gross Income Selling, General, Administrative Expenses Research and Development Depreciation Expenses Operating Income (EBIT) Interest Expense Pre-tax Income Tax Net Income 52,900 12,300 40,600 14,900 7,800 5,800 12,100 3,700 8,400 1,100 7,300 Balance Sheet (in millions $) Year Ended December 31, 2016 Cash Net Receivables Inventory 20,900Accounts Payable 11,300 Short Term Debt 9,400 21,700 6,800 Current Assets 39,000 Current Liabilities 31,100 Net Property, Plant, Equipment 132,600 Long Term Debt 80,900 Total Liabilities 112,000 59,600 171,600 Total Stockholders' Equit Total Assets 171,600Total Liabilities and Equit Assume the following:1) net property, plant, and equipment for the year ended December 31, 2015 was $123,600M; (2) long-term debt for the year ended December 31, 2015 was $73,300M; and (3) pro- forma short-term debt is calculated based on its percentage of COGS from 2016 (similar to how you calculate pro-forma accounts payable)